Skyler showed an early interest in technology and healthcare. At the age of 15, Edson purchased used computers in order to take them apart to see how they worked. In college, Skyler started building computers and selling them directly to physicians and hospitals, focusing on strong personal customer support and customized software. It was right after medical school that Edson joined a large pharmaceutical company and worked up the ranks to become the Chief Medical Officer of this thriving company. Later Edson found the niche that would become a boom --- which was the combination of leveraging technology to drive the pharmaceutical development process.

Skyler is one of the ultimate decision-makers for anything business transformational. He grows the company through innovative technology advancements and acquisitions and doesn’t mind being on the “cutting edge.” Skyler often speaks publicly about his company’s commitment to science and technology. A sign hangs in his office that says, “Saving the world, one patient at a time.” Today Skyler has diversified the company into an emerging powerhouse covering several key therapeutic areas of which some of these have huge potential and others are unknown.

Campbell is a transformative force in the life sciences realm, recently joining Sitravon as the Chief Information Officer (CIO). With more than two decades of experience straddling the domains of technology and life sciences, Campbell has cemented the position of a trailblazer within the industry. This academic journey is continuing with a current pursuit toward a Ph.D. in Bioinformatics, allowing to sharpen skills in data-driven research and decision-making. This should be complete by 2024. Campbell’s pioneering approach to harnessing technology for breakthroughs in life sciences should uniquely position Sitravon Scientific as a global frontrunner.

In previous CIO roles, Campbell took the lead in enhancing that company's operations through practical measures and process redesign. Campbell's knack for bridging the gap between science and technology not only streamlined internal processes but also played a pivotal role in driving operational excellence and decreasing the I.T. cost burdens on the company. Beyond these professional responsibilities, Campbell actively engages in mentorship programs, advocating for the continuous improvement of operational aspects and efficiency in the life sciences, thereby contributing to the industry's steady growth of digital transformation.

Murphy Bannon is an accomplished industry leader focused on digital transformation, currently holding the pivotal new role of Chief Digital “Transformation” Officer (CDO) at Sitravon. With an extensive background in digital strategy and technology integration from the consumer retail world, Murphy is poised to be a driving force behind Sitravon's evolution into a modern powerhouse in the life sciences sector and is referred internally as “The Change Maker.”

Murphy's career journey is a testament to the deep-rooted passion for bridging the gap between technology and business applications. Armed with a Bachelor's degree in Information Technology and a Master's in Data Science, this demonstrates a unique blend of skills that can translate complex scientific advancements into digital solutions. Even in a very short time this visionary leadership has been instrumental in guiding Sitravon's digital transformation initiatives, which are starting to revolutionize the way the company conducts research, development, and operational processes. Under this guidance, Sitravon is open to emerging technologies like AI, big data analytics, and IoT with Med-Devices, positioning the company at the forefront of digital innovation within the life sciences sector. Murphy Bannon's commitment to advancing digital transformation in life sciences will not only redefine the company's operations but will set a new standard for technological excellence within the industry.

Parker Corbett is a seasoned financial strategist and has been the Chief Financial Officer (CFO) of Sitravon for the past year. With a wealth of experience in financial management and a sharp focus on economic strategy, Parker plays a pivotal role in steering Sitravon towards financial success and sustainable growth.

Parker's career has been marked by a relentless pursuit of excellence in the financial sector. Armed with an MBA in Finance and a rich background in corporate finance and investment analysis, Parker brings a unique blend of analytical skills and financial acumen to the role. Featuring meticulous financial planning and strategic decision-making this has shown to be instrumental in driving Sitravon's financial health and stability, ensuring that the company has the resources and fiscal discipline needed to pursue groundbreaking research and development in the life sciences sector. Under Parker's guidance, Sitravon has achieved remarkable fiscal growth and stability, enabling the company to secure critical investments for its innovative projects. This dedication to ensuring the financial strength of Sitravon has not only fueled the company's operational success but has also set new benchmarks for financial excellence within the life sciences industry.

Transitioning into the pharmaceutical industry, Morgan held key positions in research and development, where they demonstrated a unique ability to translate scientific discoveries into actionable strategies for drug development. Their experience encompasses drug discovery, preclinical and clinical development, and regulatory affairs, providing them with a comprehensive understanding of the drug development process.

At Sitravon, Morgan leads the company's scientific endeavors, overseeing research programs, collaborations, and partnerships aimed at advancing the company's pipeline of innovative therapies. With a focus on scientific excellence, innovation, and patient-centricity, Morgan guides Sitravon in its pursuit of novel treatments for unmet medical needs.

Through strategic collaborations with academic institutions, biotechnology partners, and contract research organizations, Morgan drives Sitravon's scientific strategy forward, ensuring that the company remains at the forefront of pharmaceutical innovation. By fostering a culture of curiosity, collaboration, and integrity, Morgan plays a pivotal role in shaping Sitravon's future as a leader in scientific discovery and drug development.

With a robust background in pharmaceuticals and a passion for advancing healthcare through data-driven insights, Alex Taylor brings invaluable expertise to Sitravon as the Head of Clinical Data Management.

Alex's journey in the pharmaceutical industry spans over a decade, marked by a series of impactful roles that have honed their skills and vision. Graduating with honors in Biomedical Sciences, Alex began their career as a Clinical Data Coordinator at a leading research institute, where they quickly distinguished themselves for their meticulous attention to detail and strategic approach to data management.

Driven by a relentless pursuit of excellence, Alex progressed to more senior positions within renowned pharmaceutical companies, assuming responsibilities in project management, clinical operations, and data analysis. Their diverse experience across different facets of drug development has equipped them with a comprehensive understanding of the clinical trial lifecycle and the critical role data plays in driving informed decision-making.

At Sitravon, Alex leads a dynamic team of data management professionals, overseeing the end-to-end process of clinical data collection, analysis, and reporting. With a focus on efficiency, quality, and compliance, Alex spearheads initiatives to streamline data management processes, implement innovative technologies, and foster a culture of continuous improvement.

Drawing upon their expertise and industry insights, Alex is committed to leveraging data to accelerate the development of life-changing therapies and enhance patient outcomes. As the pharmaceutical landscape evolves, Alex remains at the forefront, guiding Sitravon towards excellence in clinical data management and reinforcing the company's reputation for innovation and integrity.

With a proven track record of driving commercial success in the pharmaceutical industry, Casey Jenkins brings dynamic leadership and strategic vision to their role as Chief Commercial Officer at Sitravon.

Casey’s career trajectory encompasses diverse roles in sales, marketing, and strategic planning, honing their expertise in market analysis, product launch strategies, and customer engagement. With a background in business administration and a keen understanding of market dynamics, Casey has consistently delivered results by translating market insights into actionable commercial strategies.

At Sitravon, Casey leads the company's commercialization efforts, overseeing sales, marketing, market access, and business development initiatives globally. With a focus on customer-centricity and innovation, Casey drives the development and execution of comprehensive commercial strategies to maximize the potential of Sitravon's portfolio of products.

Through strategic partnerships, targeted marketing campaigns, and a relentless focus on delivering value to customers and patients, Casey plays a pivotal role in driving revenue growth and market expansion for Sitravon Pharmaceuticals. By aligning commercial activities with the company's overarching mission and values, Casey contributes to Sitravon's position as a trusted partner in improving healthcare outcomes worldwide.

Baylor is the Senior Director of Marketing Analytics at Sitravon. With over 15 years of experience in commercial analytics across large pharma and agile biotechs, Baylor leads a high-performing team responsible for translating data into strategic action across Sitravon's portfolio. His remit includes campaign optimization, HCP engagement analysis, channel mix evaluation, and field alignment for both established therapies and upcoming launches.

At Sitravon, Baylor is navigating a complex and rapidly evolving market landscape. One of his primary challenges is improving the ROI of omnichannel marketing efforts in a post-COVID environment where traditional rep access has not fully recovered. With multiple touchpoints across digital, field, and peer-to-peer channels, Baylor is under pressure to help Sitravon brand leads prioritize investments that drive measurable engagement—especially for high-cost therapies with small prescriber bases. He's also working to implement more agile, real-time campaign performance tracking so brand teams can pivot messaging, cadence, or targeting without waiting for quarterly data refreshes.

Another major focus for Baylor is bridging the data-to-decision gap across marketing and sales leadership. Despite having access to robust datasets, there's a disconnect in how insights are shared and used. Executive stakeholders often receive overly technical reports that lack clear business recommendations. To solve this, Baylor is championing a communication shift: moving from static dashboards to executive-ready insight narratives that tell a story, propose actions, and align with brand KPIs. This has required upskilling his team in data storytelling and working with external partners who can operate with the same level of strategic fluency.

Baylor is also working to improve coordination with Sales Analytics and Field Operations, particularly around pre-call planning and promotional resource allocation. With increasingly granular data on physician responsiveness and digital engagement, there's an opportunity to create dynamic targeting models that adjust based on in-market behavior. However, internal alignment and effective communication of these recommendations remain hurdles. He values vendor partners who can not only run the models but present their implications in a way that resonates with business stakeholders and can be operationalized quickly.

Landry is the Senior Director of Sales Analytics at Sitravon, reporting directly to Chief Commercial Officer Casey Jenkins. With over a decade of experience in pharmaceutical sales operations and commercial effectiveness, Landry leads the strategic analytics function that supports sales forecasting, field force optimization, and physician engagement insights across Sitravon’s therapeutic care portfolio. Known for her disciplined, data-driven mindset and strong alignment with commercial leadership, Landry plays a pivotal role in ensuring the sales organization is both agile and accountable in an increasingly competitive market.

At Sitravon, Landry is focused on transforming sales analytics from a reporting function into a proactive performance accelerator. A major challenge she's tackling is improving call planning precision and field force productivity in markets where prescriber access is limited and variability across territories is high. Landry’s team is building predictive models that combine CRM activity, prescribing trends, and digital touchpoints to identify high-potential physicians and recommend next-best-actions to reps. However, she recognizes that the effectiveness of these models depends on clear communication and strong field buy-in—something she's actively working to improve.

Landry is also addressing the persistent challenge of forecast accuracy, especially for new product launches where historical analogs are limited. She’s leading a cross-functional initiative to enhance the company’s forecasting process by integrating real-time data sources and scenario-based modeling. This effort has elevated the role of Sales Analytics in brand planning cycles, but it’s also increased the stakes: Landry and her team are now expected to deliver forecasts that hold up to executive scrutiny and can be clearly explained to finance, supply chain, and investor relations teams.

A key part of Landry’s strategy is improving alignment between Sales, Marketing, and Managed Markets Analytics. With each function using different tools and terminology, there's often a gap in how insights are interpreted and acted upon. Landry is working closely with Casey Jenkins to create a unified commercial data platform and common KPI structure.

For Landry, meetings must be productive, presentations must lead to decisions, and every insight must tie back to measurable field impact. She values partners who can deliver not just numbers, but strategic guidance—those who can distill complexity into executive-ready recommendations.

With a distinguished career spanning clinical practice, research, and pharmaceutical leadership, Cameron Taylor brings a wealth of expertise and insight to their role as Chief Medical Officer at Sitravon.

Cameron's journey in medicine began with a passion for patient care, leading them to pursue a Doctor of Medicine degree followed by specialized training in a chosen therapeutic area. Their clinical experience provided them with firsthand knowledge of patient needs and the challenges faced in delivering optimal healthcare outcomes.

Transitioning into the pharmaceutical industry, Cameron held key roles in medical affairs, clinical development, and regulatory affairs, where they demonstrated a commitment to advancing medical science and improving patient care through innovative therapies.

As Chief Medical Officer at Sitravon, Cameron provides strategic leadership and medical oversight across all aspects of the company's research and development programs. Leveraging their deep understanding of clinical medicine and regulatory requirements, Cameron guides the development of Sitravon's pipeline, ensuring alignment with patient needs and market opportunities.

Driven by a passion for innovation and a dedication to improving global health, Cameron leads Sitravon in its pursuit of groundbreaking therapies that address unmet medical needs and enhance patient outcomes. Through collaborative partnerships and a commitment to scientific excellence, Cameron plays a pivotal role in shaping Sitravon's future as a leader in pharmaceutical innovation.

With a proven track record of leadership and operational excellence in the pharmaceutical industry, Jordan Lee brings a wealth of experience and expertise to their role as Head of Clinical Operations at Sitravon.

Jordan's journey in healthcare began with a Bachelor's degree in Health Sciences, followed by a Master's in Clinical Research Management, laying the foundation for their illustrious career. Starting as a Clinical Research Associate, Jordan quickly rose through the ranks, demonstrating a keen understanding of clinical trial management and a commitment to driving efficiency and quality in every project.

Throughout their career, Jordan has held key leadership positions in clinical operations, overseeing complex trials across various therapeutic areas. Their strategic approach to project planning, resource allocation, and stakeholder management has been instrumental in delivering successful outcomes and meeting ambitious timelines.

At Sitravon, Jordan leads a dedicated team of clinical operations professionals, responsible for the planning, execution, and monitoring of clinical trials. With a focus on operational excellence, Jordan collaborates closely with cross-functional teams to optimize trial protocols, mitigate risks, and ensure compliance with regulatory requirements.

Driven by a passion for advancing patient care, Jordan is committed to implementing innovative approaches and best practices to streamline clinical operations and accelerate the development of novel therapies. By fostering a culture of collaboration, accountability, and continuous improvement, Jordan plays a pivotal role in Sitravon's mission to transform healthcare through groundbreaking research and development.

With over 15 years of experience in pharmaceutical manufacturing, Taylor Patel is a seasoned leader known for their strategic vision and operational expertise. Taylor's career trajectory includes roles in production management, supply chain optimization, and quality assurance, providing them with a comprehensive understanding of the complexities of global manufacturing.

At Sitravon, Taylor leads the company's global manufacturing operations, overseeing a network of production facilities to ensure the timely and efficient delivery of high-quality pharmaceutical products. With a focus on innovation and continuous improvement, Taylor drives initiatives to optimize manufacturing processes, enhance product quality, and meet regulatory requirements.

Through collaborative leadership and a commitment to excellence, Taylor plays a pivotal role in Sitravon's mission to provide patients worldwide with access to life-saving medications.